【24h】

Multiphoton imaging in mouse models of Alzheimer's disease

机译:阿尔茨海默氏病小鼠模型中的多光子成像

获取原文
获取原文并翻译 | 示例

摘要

Alzheimer's disease is characterized by the presence of neurofibrillary tangles and senile plaques in the brain. Clinical techniques are just becoming available for detecting plaques, allowing a definitive diagnosis of the disease. Using multiphoton microscopy and transgenic mouse models that develop senile plaques as they age, we have demonstrated chronic, in vivo imaging of these neuropathological lesions. We have used these tools to evaluate contrast agents with high affinity and specificity for senile plaques that would be suitable for non-invasive imaging with PET scanning if appropriately radiolabeled. These imaging tools should translate into early diagnostic procedures, as well as end-points for clinical trials aimed at clearing senile plaques from the brain. We have also developed FLIM for FRET determinations in vitro and in vivo between appropriate donor and acceptor fluorophores to examine the proximity of domains within a single protein. These results indicate that FRET measurements using FLIM can determine interactions of proteins on the nanometer scale, facilitating an understanding of both static and dynamic protein assemblies in neuropathological diseases.
机译:阿尔茨海默氏病的特征是大脑中存在神经原纤维缠结和老年斑。临床技术正变得可用于检测斑块,从而可以明确诊断该疾病。使用多光子显微镜和随着年龄增长而形成老年斑的转基因小鼠模型,我们已经证明了这些神经病理病变的慢性体内成像。我们已经使用这些工具来评估对老年斑具有高亲和力和特异性的造影剂,如果适当地进行了放射性标记,这些造影剂将适合采用PET扫描的非侵入性成像。这些成像工具应转化为早期诊断程序,以及旨在清除大脑中老年斑的临床试验的终点。我们还开发了FLIM,用于在体外和体内在合适的供体和受体荧光团之间进行FRET测定,以检查单个蛋白内结构域的接近性。这些结果表明,使用FLIM进行FRET测量可以确定纳米级蛋白质的相互作用,从而有助于理解神经病理疾病中的静态和动态蛋白质组装。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号